PANoptosis in Sepsis: A Central Role and Emerging Therapeutic Target

Qiqi Wu1, Siyuan Qi1, Zhaofeng Kang1

  • 1Trauma Center/Department of Emergency and Traumatic Surgery, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.

Insights

PANoptosis, a novel cell death form, drives sepsis inflammation and organ damage. Targeting PANoptosis offers promising new sepsis treatments.

Area of Science:

  • Immunology
  • Cell Biology
  • Pathophysiology

Background:

  • Sepsis pathogenesis involves regulated cell death.
  • PANoptosis is a novel regulated cell death pathway.
  • PANoptosis critically influences sepsis progression.

Purpose of the Study:

  • To review molecular mechanisms of PANoptosis in sepsis.
  • To explore PANoptosis's role in sepsis pathogenesis.
  • To discuss therapeutic strategies targeting PANoptosis.

Main Methods:

  • Literature review of PANoptosis and sepsis.
  • Analysis of molecular pathways involved in PANoptosis.
  • Evaluation of therapeutic interventions.

Main Results:

  • PANoptosis activates inflammatory cytokine release, causing a "cytokine storm."
  • It impairs immune cell function and leads to multi-organ dysfunction.
  • PANoptosis exacerbates sepsis-induced organ damage.

Conclusions:

  • PANoptosis is a key driver of sepsis pathology.
  • Targeting PANoptosis presents a promising therapeutic strategy for sepsis.
  • Novel treatments for sepsis may emerge from targeting PANoptosis.